Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and May 2026.
- Largest single sale: $1.2M (2,437 shares) of Vertex Pharmaceuticals on Feb 17, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | EVP, Chief Scientific Officer | Feb 3, 2026 | May 19, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 15, 2026, Vertex Pharmaceuticals: sold 33 shares for $15K, under a disclosed plan. 1 filing: 1
- Feb 25, 2026, Vertex Pharmaceuticals: sold 620 shares for $302K, under a disclosed plan. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 582 shares withheld by the company for taxes. 1 filing: 1
- Feb 18, 2026, Vertex Pharmaceuticals: sold 1,182 shares for $560K, under a disclosed plan. 1 filing: 1
- Feb 17, 2026, Vertex Pharmaceuticals: sold 2,437 shares for $1.2M, under a disclosed plan; 2,584 shares granted; 1,110 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.